Reckitt, the consumer goods group known for products like Nurofen, reported a drop in its fourth-quarter like-for-like net revenue, missing analyst expectations. The company announced its Q4 earnings with a net revenue of GBP 56 billion, against an estimated GBP 3.69 billion, and a like-for-like sales decrease of 1.2%, compared to the expected increase of 1.75%. For the full year, like-for-like sales grew by 3.5%, missing the forecast of 4.15%. The decline in sales was attributed to a slowdown in sales of cold and flu season products, alongside issues such as slowed price increases and volume declines. Additionally, Reckitt Benckiser faced a profit drop and a sales slump, partly due to an accounting issue in the Middle East. Shares of Reckitt Benckiser slid following the announcement of these results.